These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8103874)

  • 21. Left ventricular function after late thrombolysis with alteplase in myocardial infarction.
    Gil VM; Ventosa A; Antunes AF; Morais J; Seabra-Gomes R
    Rev Port Cardiol; 1996 May; 15(5):413-20, 366. PubMed ID: 8763515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK).
    Neuhaus KL; von Essen R; Tebbe U; Jessel A; Heinrichs H; Mäurer W; Döring W; Harmjanz D; Kötter V; Kalhammer E
    Circulation; 1994 Oct; 90(4):1638-42. PubMed ID: 7923646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
    N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombolytic treatment in acute myocardial infarction.
    Verstraete M
    Circulation; 1990 Sep; 82(3 Suppl):II96-109. PubMed ID: 2118432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Argatroban and alteplase in patients with acute myocardial infarction: the ARGAMI Study.
    Vermeer F; Vahanian A; Fels PW; Besse P; Müller E; Van de Werf F; Fitzgerald D; Darius H; Puel J; Garrigou D; Simoons ML;
    J Thromb Thrombolysis; 2000 Dec; 10(3):233-40. PubMed ID: 11122543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of reteplase with alteplase for acute myocardial infarction.
    Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators
    N Engl J Med; 1997 Oct; 337(16):1118-23. PubMed ID: 9340503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation and comparison of the adverse effects of streptokinase and alteplase.
    Tisdale JE; Colucci RD; Ujhelyi MR; Kluger J; Fieldman A; Chow MS
    Pharmacotherapy; 1992; 12(6):440-4. PubMed ID: 1492007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LATE assessment of thrombolytic efficacy with alteplase (rt-PA) six-24 hours after onset of acute myocardial infarction.
    Bett JH
    Aust N Z J Med; 1993 Dec; 23(6):745-8. PubMed ID: 8141717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retreatment with alteplase for early signs of reocclusion after thrombolysis. The European Cooperative Study Group.
    Simoons ML; Arnout J; van den Brand M; Nÿssen K; Verstraete M
    Am J Cardiol; 1993 Mar; 71(7):524-8. PubMed ID: 8438737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomes.
    Mehta RH; Alexander JH; Van de Werf F; Armstrong PW; Pieper KS; Garg J; Califf RM; Granger CB
    JAMA; 2005 Apr; 293(14):1746-50. PubMed ID: 15827313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of myocardial ischemia six months after thrombolytic treatment of acute coronary episodes. A subset of a placebo controlled, randomised trial, the ASSET Study.
    Vaage-Nilsen M; Aurup P; Høegholm A; Eidemark I; Rasmussen V; Jensen G
    Int J Cardiol; 1993 Jun; 39(3):187-93. PubMed ID: 8101512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).
    Wilcox RG; von der Lippe G; Olsson CG; Jensen G; Skene AM; Hampton JR
    Lancet; 1988 Sep; 2(8610):525-30. PubMed ID: 2900919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic delay and reduced functional status six months after thrombolysis for acute myocardial infarction.
    Avorn J; Knight E; Ganz DA; Schneeweiss S
    Am J Cardiol; 2004 Aug; 94(4):415-20. PubMed ID: 15325921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An angiographic assessment of alteplase: double-bolus and front-loaded infusion regimens in myocardial infarction. DouBLE Study Investigators. Double Bolus Lysis Efficacy.
    Bleich SD; Adgey AA; McMechan SR; Love TW
    Am Heart J; 1998 Oct; 136(4 Pt 1):741-8. PubMed ID: 9778080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial.
    Bluhmki E; Chamorro A; Dávalos A; Machnig T; Sauce C; Wahlgren N; Wardlaw J; Hacke W
    Lancet Neurol; 2009 Dec; 8(12):1095-102. PubMed ID: 19850525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction.
    Sinnaeve PR; Alexander JH; Bogaerts K; Belmans A; Wallentin L; Armstrong P; Adgey JA; Tendera M; Diaz R; Soares-Piegas L; Vahanian A; Granger CB; Van De Werf FJ
    Am Heart J; 2004 Jun; 147(6):993-8. PubMed ID: 15199346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina.
    Neri Serneri GG; Gensini GF; Poggesi L; Trotta F; Modesti PA; Boddi M; Ieri A; Margheri M; Casolo GC; Bini M
    Lancet; 1990 Mar; 335(8690):615-8. PubMed ID: 1969013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.